Patent Assignment
Reel/Frame 028363/0727
Change of Name
Recorded: 2012-06-12
Pages: 4
Assignor
MYRIAD PHARMACEUTICALS, INC.
Executed: 2010-06-30
Assignee
MYREXIS, INC.
305 CHIPETA WAY, SALT LAKE CITY, UTAH, 84108
Covered Property
(1)
Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Apr 13, 2012
From: PANACOS PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 028040/0628 →
Corrective Assignment to Correct the Conveyance Type of the Assignment to an Asset Purchase Agreement and to Correct the Assignee's Mailing Address Previously Recorded on Reel 028040 Frame 0628. Assignor(S) Hereby Confirms the Assignment of Assignor's Interest in an Asset Purchase Agreement Dated October 15, 2009..
Apr 26, 2012
From: PANACOS PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 028116/0010 →
Corrective Assignment to Correct the Name and Address of the Receiving Party Previously Recorded on Reel 028116 Frame 0010. Assignor(S) Hereby Confirms the Assignment of Assignor's Interest in an Asset Purchase Agreement Dated October 15, 2009..
May 31, 2012
From: PANACOS PHARMACEUTICALS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 028307/0209 →